The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC

Full description

Bibliographic Details

Published in:	Cancer immunology immunotherapy. - Springer Berlin Heidelberg, 1976. - 71(2022), 9 vom: 23. Jan., Seite 2151-2168
Main Author:	Guti, Eliza (Author)
Other Authors:	Regdon, Zsolt (Author) Sturniolo, Isotta (Author) Kiss, Alexandra (Author) Kovács, Katalin (Author) Demény, Máté (Author) Szöőr, Árpád (Author) Vereb, György (Author) Szöllősi, János (Author) Hegedűs, Csaba (Author) Polgár, Zsuzsanna (Author) Virág, László (Author)
Format:	electronic Article
Language:	English
Published:	2022
ISSN:	1432-0851
External Sources:	kostenfrei